Delivery Order SPE2DB22D3016-SPE2DB25FBDS1
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for the supply of Prevymis 480 mg tablets in quantities of 7 per unit. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This is a firm fixed-price contract with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $9.4K delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 16, 2025. This delivery order is issued as...
- The Defense Logistics Agency awarded a $18,877.36 delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packaging) under a firm fixed price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $18.88K delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of PREVYMIS 480 mg tablets (seven-count packaging). This is a competitively awarded, firm fixed-price contract with no set-aside designation, with performance to be completed by July 16, 2025, and fulfillment based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded a $18,877.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 mg tablets (7-count packaging) on July 14, 2025, with an ultimate completion date of August 4, 2025. The award was competitively procured with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $4,719.34. The contract type is a delivery order with an ultimate completion date of October 7, 2025, and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $1,406.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg/24 ml vials. The contract, issued on September 1, 2025, with an ultimate completion date of September 22, 2025, represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $12,861.06 by the Defense Logistics Agency (DLA) Troop Support Medical to supply Prevymis 480 mg tablets. The order was awarded on December 14, 2023 with a completion date of January 8, 2024 and will be performed at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing DLA contract vehicle to support the...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $4,287.02 by the Defense Logistics Agency Troop Support Medical (DLA) to supply 480 mg tablets of Prevymis. Performance will take place in Conshohocken, Pennsylvania over a period of approximately one month, from September 21, 2023 through October 13, 2023. No subcontractors or set aside designations were indicated. DLA manages the Department of...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDS1Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,719.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order supports the Defense Logistics Agency's mission to supply critical pharmaceutical products to military and veteran healthcare systems. Prevymis, an antiviral medication used in immunocompromised patients, demonstrates the breadth of specialized medical commodities delivered through AmerisourceBergen's federal contract portfolio. The award reflects the contractor's capability to fulfill competitive federal procurement requirements across a wide spectrum of therapeutic domains, with DLA Troop Support planning to expand the Pharmaceutical Prime Vendor Global Program Generation V through multiple regional awards involving multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 7/31/25 |